Rich Pharmaceuticals Inc. (fka RCHA)

[Peddler22]

The unknown here is who will own rp-323. Hmgn will have the rights in exchange for shares of their common stock going to us however if chang doesn’t receive 1 million in financing from hmgn by july 28 2019 the deal is off and rcha retains all rights and patents. This is a high reward play. Pps reflects the risk associated but the reality is rp-323 is for real and could be a game and life changer for many Imo chang will excersise his right to maintain patent ownership and other funding will become available as part 1 of 2 clinical trials concludes and confirms this spring. Hmgn has yet to deliver on any of the terms. Once clarity of ownership is established we soar to new support levels instantly and then wait for the big bucks to follow from trial results. Two plays here. Part one is a bet on who will own rp-323 Part 2 is the galactic potential from what that drug can do Even if hmgn comes through and secures ownership Rcha shareholders will receive shares in hmgn. Win win imo as i see clinical trials on pace and mj litigation and implications for medicinal applications become clearer and more user friendly. This drug works is the bottom line. Rcha$$$